Health outcomes in economic evaluation: Who should value health?

British Medical Bulletin

Volumn 97, Issue 1, 2011, Pages 197-210

  Stamuli, Eugena ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

controversies; economic evaluation; health state valuation; perspective; preference; utilities

Indexed keywords

ADAPTATION; ANXIETY; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL DECISION MAKING; DEPRESSION; ECONOMIC EVALUATION; EURO QULAITY OF LIFE 5; HEALTH STATUS; HEALTH SURVEY; HEALTH UTILITIES INDEX; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SHORT FORM 6; VALIDITY; VISUAL ANALOG SCALE;

ATTITUDE TO HEALTH; COST-BENEFIT ANALYSIS; HEALTH STATUS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY-ADJUSTED LIFE YEARS;

EID: 79952553535     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldr001     Document Type: Article

References (40)

1. Palmer S, Torgerson DJ. Definitions of efficiency. BMJ 1999;318:1136.
2. Drummond MF, Sculpher MJ, Torrance GW et al. Methods for the Economic Evaluation of Health Care Programmes, 3rd edn. Oxford: Oxford University Press, 2005.
3. Brazier J, Ratcliffe J, Salomon JA et al. Measuring and Valuing Health Benefits for Economic Evaluation, 1st edn. Oxford: Oxford University Press, 2007.
4. Dolan P. Whose preferences count? Med Decis Mak 1999;19:482-6. (Pubitemid 29474774)
5. De Wit GA, Busschbach JJV, De Charro FTh. Sensitivity and perspective in the valuation of health status: whose values count? Health Econ 2000;9:109-26. (Pubitemid 30148158)
6. Green C, Brazier J, Deverill M. Valuing health-related quality of life. A review of health state valuation techniques. Pharmacoeconomics 2000;17:151-65. (Pubitemid 30148812)
7. Drummond M, McGuire A. Economic Evaluation in Health Care: Merging Theory with Practice, 1st edn. Oxford: Oxford University Press, 2001.
8. Ryan M, Netten A, Skatun D et al. Using discrete choice experiments to estimate a preference-based measure of outcome-an application to social care for older people. J Health Econ 2006;25:927-44. (Pubitemid 44251229)
9. Craig BM, Busschbach JJ, Salomon JA. Keep it simple: ranking health states yields values similar to cardinal measurement approaches. J Clin Epidemiol 2009;62:296-305.
10. Brooks R. EuroQol Group. EuroQol: the current state of play. Health Policy 1996;37:35-72.
11. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095-108. (Pubitemid 127453463)
12. Brazier JE, Czoski-Murray C, Robers J et al. Estimation of a preference-based index from a condition specific measure: the King's health questionnaire. Med Decis Mak 2008;28:113-26.
13. Horsman J, Furlong W, Feeny D et al. The Health Utilities Index (HUI): concepts, measurement properties and applications. Health Qual Life Outcomes 2003;1:1-13.
14. Hall J, Gerard K, Salkeld G et al. A cost utility analysis of mammography screening in Australia. Soc Sci Med 1992;34:993-1004.
15. Smith K, Dobson M. Measuring utility values for QALYs: two methodological issues. Health Econ 1993;2:349-55.
16. Revicki DA, Leidy NK, Brennan-Diemer F et al. Integrating patients' preferences into health outcomes assessment: the multi-attribute asthma symptom utility index. Chest 1998;114:998-1007. (Pubitemid 28495893)
17. Brazier J. Valuing Health states for use in cost-effectiveness analysis. Pharmacoeconomics 2008;26:769-79.
18. Wenstein MC, Torrance G, McGuire A. QALYs: The basics. Value Health 2009;12:S5-S9.
19. Ubel PA, Loewenstein G, Jepson C. Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Qual Life Res 2003;12:599-607. (Pubitemid 37094023)
20. Stiggelbout AM, De Vogel-Voogt E. Health State Utilities: a framework for studying the gap between the imagined and the real. Value Health 2008;11:76-87. (Pubitemid 351160878)
21. Insinga RP, Fryback DG. Understanding differences between self-ratings and population ratings for health in the EuroQoL. Qual Life Res 2003;12:611-9. (Pubitemid 37094025)
22. Tsevat J, Sherman SN, McElwee JA et al. The will to live among HIV-infected patients. Ann Intern Med 1999;131:194-8. (Pubitemid 29365002)
23. Menzel P, Dolan P, Richardson J, Olsen JA. The role of adaptation to disability and disease in health state valuation: a preliminary normative analysis. Soc Sci Med 2002;55:2149-58. (Pubitemid 36158948)
24. Sprangers M, Schwartz C. Integrating response shift into health-related quality of life research: A theoretical model. Soc Sci Med 1999;48:1507-15. (Pubitemid 29254110)
25. Kahnemann D. Determinants of health economic decision in actual practice: the role of behavioural economics. Value Health 2006;9:65-7.
26. Hanemann MW. Willingness to pay and willingness to accept: how much can they differ? Am Econ Rev 1991;81:635-47.
27. Drummond M, Brixner D, Gold M et al. Toward a consensus on the QALY. Value Health 2009;12:S31-5.
28. Montgomery AA, Harding J, Fahey T. Shared decision making in hypertension: the impact of patient preferences on treatment choice. Fam Prac 2001;18:309-13. (Pubitemid 32514687)
29. Dolan P. Valuing health related quality of life. Issues and controversies. Pharmacoeconomics 1998;15:119-27.
30. Brower WBF, Culyer AJ, Van Exel NJA et al. Welfarism vs. extra-welfarism. J Health Econ 2008;27:325-38.
31. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. Issue date: June 2008. http://www.nice.org.uk/ media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf.
32. Russell LB, Gold MR, Siegel JE et al. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-effectiveness in Health and Medicine. JAMA 1996;276:1172-7. (Pubitemid 26329746)
33. Barry BM. A Treatise on Social Justice. Theories of Justice, Vol. 1. USA: University of California Press, 1989.
34. Gold MR, Siegel JE, Russell LB et al. Cost-effectiveness in Health and Medicine. Oxford: Oxford University Press, 1996.
35. Dolan P, Olsen JA, Menzel P et al. An inquiry into the different perspectives that can be used when eliciting preferences in health. Health Econ 2003;12:545-51. (Pubitemid 36818031)
36. Nord E, Pinto J, Richardson J et al. Incorporating societal concerns for fairness in numerical valuations of health programs. Health Econ 1999;8:25-39. (Pubitemid 29057353)
37. Dolan P, Kahneman D. Interpretation of utility and their implications for the valuation of health. Econ J 2008;118:215-34.
38. Brazier J, Akehurst R, Brennan A et al. Should patients have a greater role in valuing health states? Appl Health Econ Health Policy 2005;4:201-8. (Pubitemid 43242208)
39. Williams A. Is the QALY a technical solution to a political problem? Of course not! Int J Health Serv 1991;21:365-9.
40. Kind P, Lafata JE, Matuszewski K et al. The use of QALYs in clinical and patient decisionmaking: issues and prospects. Value Health 2009;12:S27-30.